Yorkview Nursing And Rehabilitation
YORKVIEW NURSING AND REHABILITATION in YORK, PA — inspection on March 31, 2026.
Found 1 citation. Severity: Standard violations.
Health inspections identify deficiencies that facilities must correct within required timeframes. Violations range from minor documentation issues to serious safety concerns and are subject to follow-up verification.
Inspection Findings
Review of Resident 2's clinical record revealed diagnoses that included asthma (a chronic, long-term lung disease that causes inflammation and narrowing of the airways, making breathing difficult) and chronic pain due to trauma (a complex condition where the nervous system becomes sensitized, often causing pain to persist long after injuries heal).
Review of Resident 2's census information revealed an admission date to the facility of March 17, 2026.
Review of Resident 2's physician's orders revealed the following orders dated March 17, 2026:1.
Advair HFA Inhalation Aerosol 230-21 MCG/ACT (Fluticasone-Salmeterol) 2 puff inhale orally every morning and at bedtime for asthma.2.
Pregabalin capsule 100 MG Tab [also known as Lyrica] take 1 capsule by mouth 3 times daily for pain.3.
Celecoxib [also known as Celebrex] give 200 MG by mouth 2 times a day for arthritis.4.
Amphetamine Dextroamphetamine [also known as Adderall] 30 mg: Give one tablet every morning and at bedtime for ADHD. A review of Resident 2's interdisciplinary progress notes revealed that documentation on those medications was marked not available on March 17, 2026. An interview with the Director of Nursing on March 31, 2026, confirmed the medications documented as not available had not been received by the facility's contracted pharmacy in order to administer to Resident 2 as ordered by the physician. 28 Pa.
Code 211.9 (a) (1) (d) Pharmacy services28 Pa.
Code 211.12 (d) (1) (5) Nursing services Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided.
For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER TITLE (X6) DATE REPRESENTATIVE'S SIGNATURE